SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-045500
Filing Date
2019-09-20
Accepted
2019-09-20 17:13:02
Documents
7
Period of Report
2019-11-04
Effectiveness Date
2019-09-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv529715-def14a.htm DEF 14A 954119
2 GRAPHIC fc_neos-4c.jpg GRAPHIC 302805
3 GRAPHIC lg_phibrocorp-cmyk.jpg GRAPHIC 266855
4 GRAPHIC sg_thomas-dagger.jpg GRAPHIC 102539
5 GRAPHIC tv529715-ceotdc_bar.jpg GRAPHIC 136282
6 GRAPHIC tv529715_pc01.jpg GRAPHIC 930334
7 GRAPHIC tv529715_pc02.jpg GRAPHIC 532907
  Complete submission text file 0001144204-19-045500.txt   3937962
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36410 | Film No.: 191105399
SIC: 2834 Pharmaceutical Preparations